SupplementsVideo Summary

Paul Stamets on How Medicinal Mushrooms May Boost Immunity, Cognition and Mood

Mycologist Paul Stamets tells Andrew Huberman how fungi may support immune defense, brain plasticity and mental health, including psilocybin's risks.

Tuesday, November 17, 2026 0 views
Published in Huberman Lab
fresh lion's mane and reishi mushrooms on a wooden table beside a small jar of mushroom powder

Summary

In this Huberman Lab episode, mycologist Paul Stamets discusses how mushrooms and other fungi may influence the immune system, cognition and mental health. He covers medicinal species such as turkey tail and agarikon for antiviral and immune support, and non-psychedelic mushrooms like lion's mane, cordyceps and reishi for brain plasticity and cognitive function. The conversation also turns to psilocybin for depression and anxiety, including dosing, microdosing, legality and who faces higher risk. Stamets also talks about fungi on the skin and gut, antifungals, and using fungi to clean up environmental pollutants. Because this is a conversation and not a controlled study, the claims reflect expert opinion and should be treated as hypotheses, not proven medical advice. Listeners interested in supplements for immune and brain health will find useful discussion, along with a reminder to check the evidence behind each claim.

Detailed Summary

Interest in mushrooms as tools for immune resilience and brain health keeps growing, yet the evidence is uneven and often mixed with marketing. This episode of Huberman Lab offers a long conversation with Paul Stamets, a prominent mycologist, about what fungi may do for human health, and it is worth hearing as a source of hypotheses and not settled clinical guidance.

The discussion is based on the episode description and timestamps, not on a controlled study. Stamets and host Andrew Huberman cover fungal evolution and biology, the role of mycelium in immunity, and his personal path into mycology. They then move through medicinal species including turkey tail and agarikon, their proposed antiviral properties, and the idea that they could enhance vaccine responses. Later segments address cognitive mushrooms such as lion's mane, cordyceps and reishi, and psilocybin for depression and anxiety.

Based on the outline, the main claims are that certain mushrooms may support immune function and help with colds, that some non-psychedelic species may enhance cognition and neuroplasticity, and that psilocybin may help with depression, anxiety and other conditions. The episode also covers microdosing, the so-called Stamets Stack, differences between pharmaceutical and whole-mushroom psilocybin, legality, and safety. Other topics include fungi on the skin and gut, antifungals, and mycoremediation.

For health-conscious listeners and clinicians, the value lies in identifying which claims have human trial support and which rest on preclinical work or anecdote. Safety discussion matters, especially for people at increased risk from psilocybin, such as those with certain psychiatric vulnerabilities.

Caveats are significant. This summary rests on the episode description and chapter list only, with no transcript or data. The guest sells mushroom products, which is a potential conflict of interest, and the sponsors are also commercial. Claims about antiviral effects, vaccine enhancement and cognition should be checked against randomized trials before changing any health practice.

Key Findings

  • Stamets discusses turkey tail and agarikon as mushrooms with proposed antiviral and immune-supporting properties.
  • Non-psychedelic mushrooms such as lion's mane, cordyceps and reishi are discussed for cognition and brain plasticity.
  • Psilocybin is discussed for depression and anxiety, with attention to dosing, legality and higher-risk groups.
  • Microdosing and the 'Stamets Stack' are covered for mood, anxiety and psychomotor effects.
  • The guest has commercial mushroom-supplement interests, so claims need independent trial verification.

Methodology

This is a long-form podcast interview, not a study. The summary is based only on the episode description and timestamps, with no transcript or primary data available. No methodology, sample or outcome measures are reported.

Study Limitations

This summary is based on the episode description and chapter list only, not a transcript or peer-reviewed data. Claims are expert opinion from a guest with commercial interests in mushroom products. Evidence for antiviral, vaccine-enhancing and cognitive effects in humans may be limited or preliminary.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: